Likvor goes - UK

The unique Likvor CELDA® System is now available on the UK market and the first system has been sent to a customer. In addition, Likvor AB has signed a distribution agreement with its first distributor for this region. The system helps to restore normal life back to millions of dementia patients with hydrocephalus diagnosis. Likvor AB takes an important step out on the European market by signing a distribution agreement for the UK market with Seren Medical Ltd. Seren Medical is a company specializing in sales, marketing, service and support of state-of-the-art medical equipment. The Likvor CELDA® System is being successfully used in leading neurological clinics in Sweden, Denmark and Finland. Statistics show that 1 in 10 dementia patients suffer from an undiagnosed or misdiagnosed condition known as treatable or reversible dementia (NPH - normal pressure hydrocephalus). The symptoms of NPH commonly include difficulty in walking, urinary incontinence, and mild dementia. The condition generally manifests in over 55 year-olds. In contrast to dementia, NPH can be treated by means of a simple operation to give sufferers a completely new lease on life. Studies indicate that approximately 1.4 million patients in Europe, USA and Japan suffer from NPH. Together with the fact that the Likvor CELDA® System is used for diagnose/exclude NPH patients from other dementia diseases as Alzheimer or Parkinson's the Likvor CELDA® System is a very useful tool for investigating shunt function. It can be used for diagnosis of existing shunts. By using the Likvor CELDA® System hospitals can make huge savings, in costs as they reduce the number of shunt reoperations and in human suffering. Likvor is an Umeå based medical device company which has developed a system to be used in neurological investigations. The Likvor CELDA® System is the result of over 30 years of research at Umeå University and Umeå University Hospital assessing cerebrospinal fluid (CSF) dynamics. Likvor is marketing the Likvor CELDA® System and CELDA® Tools. Likvor continues to develop new methods and devices in the area of CSF dynamics, together with the researchers at Umeå University and Umeå University Hospital. Please contact Likvor directly for further information. CEO, Maria Wallin Wållberg: +46 (0)70 588 6766, maria.wallinwallberg@likvor.com